129 related articles for article (PubMed ID: 3323260)
1. Pharmacokinetics of esmolol in hepatic disease.
Buchi KN; Rollins DE; Tolman KG; Achari R; Drissel D; Hulse JD
J Clin Pharmacol; 1987 Nov; 27(11):880-4. PubMed ID: 3323260
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of esmolol and ASL-8123 in renal failure.
Flaherty JF; Wong B; La Follette G; Warnock DG; Hulse JD; Gambertoglio JG
Clin Pharmacol Ther; 1989 Mar; 45(3):321-7. PubMed ID: 2563962
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite.
Sum CY; Yacobi A; Kartzinel R; Stampfli H; Davis CS; Lai CM
Clin Pharmacol Ther; 1983 Oct; 34(4):427-34. PubMed ID: 6617063
[TBL] [Abstract][Full Text] [Related]
4. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
Wiest D
Clin Pharmacokinet; 1995 Mar; 28(3):190-202. PubMed ID: 7758250
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of esmolol in children.
Wiest DB; Trippel DL; Gillette PC; Garner SS
Clin Pharmacol Ther; 1991 Jun; 49(6):618-23. PubMed ID: 1676357
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy.
de Bruijn NP; Reves JG; Croughwell N; Clements F; Drissel DA
Anesthesiology; 1987 Mar; 66(3):323-6. PubMed ID: 2881504
[TBL] [Abstract][Full Text] [Related]
8. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
10. Gas chromatographic-mass spectrometric assay for the ultra-short-acting beta-blocker esmolol.
Sum CY; Yacobi A
J Pharm Sci; 1984 Aug; 73(8):1177-9. PubMed ID: 6149299
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and urinary excretion of esmolol in humans.
Achari R; Drissel D; Matier WL; Hulse JD
J Clin Pharmacol; 1986 Jan; 26(1):44-7. PubMed ID: 2869058
[TBL] [Abstract][Full Text] [Related]
12. Esmolol-digoxin drug interaction.
Lowenthal DT; Porter RS; Achari R; Turlapaty P; Laddu AR; Matier WL
J Clin Pharmacol; 1987 Aug; 27(8):561-6. PubMed ID: 2888792
[TBL] [Abstract][Full Text] [Related]
13. Esmolol in the treatment of supraventricular tachyarrhythmias.
Das G; Ferris J
Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
[TBL] [Abstract][Full Text] [Related]
14. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
15. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.
Volz-Zang C; Eckrich B; Jahn P; Schneidrowski B; Schulte B; Palm D
Eur J Clin Pharmacol; 1994; 46(5):399-404. PubMed ID: 7957532
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.
Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD
Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
Quon CY; Gorczynski RJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
[TBL] [Abstract][Full Text] [Related]
19. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
[TBL] [Abstract][Full Text] [Related]
20. Effects of esmolol on airway function in patients with asthma.
Sheppard D; DiStefano S; Byrd RC; Eschenbacher WL; Bell V; Steck J; Laddu A
J Clin Pharmacol; 1986 Mar; 26(3):169-74. PubMed ID: 2870080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
